LPL Financial
RCKT icon

LPL Financial’s Rocket Pharmaceuticals RCKT Stock Holding History

LPL Financial’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
321,836
+165,750
+106% +$551K ﹤0.01% 4350
2026
Q1 		$559K Buy
156,086
+61,830
+66% +$246K ﹤0.01% 4663
2025
Q4 		$331K Buy
94,256
+81,320
+629% +$278K ﹤0.01% 5068
2025
Q3 		$42.2K Buy
12,936
+1,750
+16% +$5.51K ﹤0.01% 5655
2025
Q2 		$27.4K Sell
11,186
-3,382
-23% -$17.1K ﹤0.01% 5433
2025
Q1 		$97.2K Buy
14,568
+4,275
+42% +$42.2K ﹤0.01% 5050
2024
Q4 		$129K Sell
10,293
-100
-1% -$1.5K ﹤0.01% 4937
2024
Q3 		$192K Sell
10,393
-86
-0.8% -$1.76K ﹤0.01% 4740
2024
Q2 		$226K Buy
10,479
+1,297
+14% +$29.8K ﹤0.01% 4474
2024
Q1 		$247K Sell
9,182
-1,050
-10% -$29.8K ﹤0.01% 4353
2023
Q4 		$307K Sell
10,232
-534
-5% -$11.8K ﹤0.01% 4077
2023
Q3 		$221K Sell
10,766
-1,175
-10% -$21.4K ﹤0.01% 4162
2023
Q2 		$237K Sell
11,941
-1,300
-10% -$26.3K ﹤0.01% 4029
2023
Q1 		$227K Buy
+13,241
New +$259K ﹤0.01% 3947

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

LPL Financial's RCKT Position: Q2 2026 in Review

LPL Financial increased its Rocket Pharmaceuticals (RCKT) stake by 106% in Q2 2026, buying an estimated $551K and bringing the position to 321,836 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #4350.

LPL Financial first reported a position in RCKT in Q1 2023 and has held it in 14 quarters since. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • LPL Financial held 321,836 shares of Rocket Pharmaceuticals worth $1.1M as of Q2 2026.
  • LPL Financial bought 165,750 Rocket Pharmaceuticals shares in Q2 2026, an estimated $551K.
  • Rocket Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4350 holding.
  • LPL Financial first reported a position in Rocket Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.